NeuroVive Pharmaceutical AB (NEVPF) Brings Hope to the Horror of TBI
Mitochondrial medicine probably isn't the last thing your family talked about over dinner, but it may be the key to dealing with some very difficult medical conditions. NeuroVive Pharmaceutical AB (OTCQX: NEVPF) is a niche biotech company that is working on novel solutions to serious medical conditions. No one wants to be the victim of a traumatic brain injury (TBI). Not only is the initial TBI likely to cause ongoing problems, but the secondary effects of TBI can be devastating. None of this is pleasant to think about, especially because there is so little that modern medicine can do to…